Literature DB >> 33553037

Crocin attenuates oxidative stress and inflammation in myocardial infarction induced by isoprenaline via PPARγ activation in diabetic rats.

Mohammad Badavi1,2, Seyyed Ali Mard1,2,3, Mahin Dianat1,2, Neda Dashtbozorgi1,2.   

Abstract

BACKGROUND AND
PURPOSE: Hyperglycemia induced oxidative stress and inflammation lead to development of diabetic cardiomyopathy. Diabetic patients are more at risk for myocardial infarction than non-diabetics. The current study has investigated the involvement of PPARγ activation in effects of crocin as a natural carotenoid against cardiac infarction in diabetic rats.
MATERIALS AND METHODS: Diabetes was induced in male Wistar rats by streptozotocin injection (55 mg/kg, i.p) 15 min after the administration of nicotinamide (110 mg/kg). Then saline, crocin (40 mg/kg, orally) and GW9662 (1 mg/kg, as PPARγ antagonist) were injected for 4 weeks. Isoprenaline was administrated on the 27th and 28th days to induce infarction. Cardiac injury markers, antioxidant enzymes content, blood glucose level, lipid profile, pro and anti-inflammatory cytokines, and PPARγ gene expression were measured.
RESULTS: GSH, CAT content, CK-MB isoenzyme, LDH level, IL-10 and PPARγ gene expression in myocardial tissue were decreased in diabetic rats receiving isoprenaline and inflammatory cytokines TNFα and IL-6 and also plasma lipids were increased. Crocin administration significantly ameliorated inflammatory cytokines levels, CK-MB, and LDH contents and also it could enhance antioxidant capacity and PPARγ expression. However, GW9662 administration reversed the effects of crocin.
CONCLUSION: Overexpression of PPARγ in crocin treated rats and inhibition of crocin effects by GW9662 reflected the potential involvement of PPARγ pathway in the protective effects of crocin. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Crocin; Inflammation; Myocardial infarction; PPARγ; Rat

Year:  2020        PMID: 33553037      PMCID: PMC7843838          DOI: 10.1007/s40200-020-00686-y

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  43 in total

1.  Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats.

Authors:  E Altinoz; Z Oner; H Elbe; Y Cigremis; Y Turkoz
Journal:  Hum Exp Toxicol       Date:  2014-06-12       Impact factor: 2.903

2.  PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.

Authors:  Rui Wang; Lei Xi; Rakesh C Kukreja
Journal:  J Pharmacol Exp Ther       Date:  2017-01-25       Impact factor: 4.030

3.  The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study.

Authors:  Vahideh Behrouz; Ali Dastkhosh; Mehdi Hedayati; Meghdad Sedaghat; Maryam Sharafkhah; Golbon Sohrab
Journal:  Diabetol Metab Syndr       Date:  2020-07-09       Impact factor: 3.320

4.  Effects of crocin on experimental obesity and type-2 diabetes.

Authors:  Ömer Hazman; Laçine Aksoy; Ahmet Büyükben
Journal:  Turk J Med Sci       Date:  2016-11-17       Impact factor: 0.973

5.  Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure.

Authors:  Bibi Marjan Razavi; Hossein Hosseinzadeh; Ahmad Reza Movassaghi; Mohsen Imenshahidi; Khalil Abnous
Journal:  Chem Biol Interact       Date:  2013-03-21       Impact factor: 5.192

6.  Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation.

Authors:  Neha Rani; Saurabh Bharti; Jagriti Bhatia; T C Nag; Ruma Ray; Dharamvir Singh Arya
Journal:  Chem Biol Interact       Date:  2016-03-10       Impact factor: 5.192

7.  Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats.

Authors:  Syed Mohammed Basheeruddin Asdaq; Mohammed Naseeruddin Inamdar
Journal:  Appl Biochem Biotechnol       Date:  2009-08-13       Impact factor: 2.926

8.  Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats.

Authors:  Saeed Shirali; S Zahra Bathaie; Manouchehr Nakhjavani
Journal:  Phytother Res       Date:  2012-09-05       Impact factor: 5.878

9.  Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats.

Authors:  Yogeeta O Agrawal; Pankaj Kumar Sharma; Birendra Shrivastava; Shreesh Ojha; Harshita M Upadhya; Dharamvir Singh Arya; Sameer N Goyal
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 10.  PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity.

Authors:  Patricia Corrales; Antonio Vidal-Puig; Gema Medina-Gómez
Journal:  Int J Mol Sci       Date:  2018-07-21       Impact factor: 5.923

View more
  3 in total

1.  Cardioprotective Effect of Gossypin Against Myocardial Ischemic/Reperfusion in Rats via Alteration of Oxidative Stress, Inflammation and Gut Microbiota.

Authors:  Gong Cheng; Ji Zhang; Shuo Jia; Panpan Feng; Fengjun Chang; Li Yan; Pranay Gupta; Haoyu Wu
Journal:  J Inflamm Res       Date:  2022-03-05

Review 2.  Crocins for Ischemic Stroke: A Review of Current Evidence.

Authors:  Kiran Shahbaz; Dennis Chang; Xian Zhou; Mitchell Low; Sai Wang Seto; Chung Guang Li
Journal:  Front Pharmacol       Date:  2022-08-05       Impact factor: 5.988

Review 3.  Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.

Authors:  Namrita Kaur; Yingshu Guan; Rida Raja; Andrea Ruiz-Velasco; Wei Liu
Journal:  Front Physiol       Date:  2021-06-21       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.